STOCK TITAN

Regional Health Properties (RHEP) reports 2025 shareholder voting results

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Regional Health Properties, Inc. reported the results of its 2025 Annual Meeting of Shareholders held on January 5, 2026 in Atlanta. Common stockholders elected four directors to serve until the 2026 annual meeting, while holders of the Series B and Series D preferred stock each elected their designated directors.

Common stockholders approved the Amended and Restated 2023 Omnibus Incentive Compensation Plan and, by advisory vote, approved the compensation of the named executive officers. They expressed a preference to hold future Say‑on‑Pay votes every three years and ratified Cherry Bekaert, LLP as independent registered public accounting firm for the year ending December 31, 2025.

Positive

  • None.

Negative

  • None.
false000100472400010047242026-01-052026-01-05

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 5, 2026

Regional Health Properties, Inc.

(Exact Name of Registrant as Specified in its Charter)

Georgia

001-33135

81-5166048

(State or Other Jurisdiction

(Commission

(I.R.S. Employer

of Incorporation)

File Number)

Identification No.)

1050 Crown Pointe Parkway

Suite 720

Atlanta, Georgia 30338

(Address of Principal Executive Offices, and Zip Code)

(678) 869-5116

(Registrants telephone number, including area code)

Not applicable.

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).


Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Item 5.07. Submission of Matters to a Vote of Security Holders.

On January 5, 2026, the Company held its 2025 Annual Meeting of Shareholders (the “Annual Meeting”) at 1050 Crown Pointe Parkway, Atlanta, Georgia 30338 at 1:00 p.m. Following is a summary of the proposals that were submitted to the holders of the Company’s common stock, no par value per share (the “common stock”), the 12.5% Series B Cumulative Redeemable Preferred Shares, no par value per share (the “Series B Preferred Stock”), and the Series D 8.5% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share ("the Series D Preferred Stock") for approval at the Annual Meeting and a tabulation of the votes with respect to each proposal. Each proposal is further described in the Proxy Statement.

Proposal 1(a). To elect the four director nominees named in the Proxy Statement.

The common stock shareholders elected the following four individuals to the Company’s board of directors (the “Board”) to serve until the Company’s 2026 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal. The voting results were as follows:

Nominee

 

For

 

Withheld

 

Broker Non-Votes

Brent Morrison

 

1,335,011

 

41,504

 

692,268

Kenneth W. Taylor

 

1,302,440

 

74,075

 

692,268

F. Scott Kellman

 

1,306,854

 

69,661

 

692,268

C. Christain Winkle

 

1,336,996

 

39,519

 

692,268

 

Proposal 1(b). To elect the one director nominee named in the Proxy Statement.

The Series B Preferred Stock shareholders elected the following individual to the Board to serve until the Company’s 2026 Annual Meeting of Shareholders and until his successor is elected and qualified, or until his earlier death, resignation or removal. The voting results were as follows:

Nominee

 

For

 

 

Withhold

Steven L. Martin

 

729,981

 

 

17,661

 

 

Proposal 1(c). To elect the two directors nominee named in the Proxy Statement.

The Series D Preferred Stock shareholders elected the following individuals to the Board to serve until the Company’s 2026 Annual Meeting of Shareholders and until his successor is elected and qualified, or until his earlier death, resignation or removal. The voting results were as follows:

Nominee

 

For

 

 

Withhold

Steven J. Baileys

 

715,251

 

 

20,251

Gene E. Burleson

 

715,250

 

 

20,252

 

 

Proposal 2. To approve the Regional Health Properties, Inc. Amended and Restated 2023 Omnibus Incentive Compensation Plan ("the A&R Plan").

 

The common stock shareholders approved the A&R plan.. The voting results were as follows:

 

For

 

Against

 

Abstain

Broker Non-Vote

1,233,315

 

135,830

 

7,370

692,268

 

 


Proposal 3. To approve, by non-binding vote, the compensation of the named executive officers as described in the proxy statement ("Say-on-Pay").

 

The common stock shareholders approved, by non-binding vote, Say-on-Pay. The results were as follows:

 

For

 

Against

 

Abstain

Broker Non-Vote

1,229,328

 

140,251

 

6,936

692,268

 

 

Proposal 4. To hold future Say-on-Pay advisory votes:.

 

The common stock shareholders voted their preference on the frequency of Say-on-Pay votes. The results were as follows:

 

Every Year

 

Every Two Years

Every Three Years

 

Abstain

Broker Non-Vote

175,998

 

5,155

1,189,981

 

5,591

692,268

 

 

Proposal 5. To ratify the appointment of Cherry Bekaert, LLP as the Company’s independent registered public accounting firm for the year ended December 31, 2025.

The common stock shareholders ratified the appointment of Cherry Bekaert, LLP as the Company’s independent registered public accounting firm for the year ended December 31, 2025. The voting results were as follows:

For

 

Against

 

Abstain

2,062,532

 

5,222

 

1.029

* * *

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

REGIONAL HEALTH PROPERTIES, INC.

Date:

January 6, 2026

By:

/s/ Brent Morrison

Brent Morrison

Chief Executive Officer and President


FAQ

What did Regional Health Properties (RHEP) shareholders approve at the 2025 annual meeting?

Shareholders approved the Amended and Restated 2023 Omnibus Incentive Compensation Plan, endorsed executive compensation by a non-binding Say-on-Pay vote, and ratified Cherry Bekaert, LLP as independent registered public accounting firm for the year ending December 31, 2025.

Which directors were elected to the Regional Health Properties (RHEP) board?

Common stockholders elected Brent Morrison, Kenneth W. Taylor, F. Scott Kellman, and C. Christain Winkle. Series B Preferred Stock holders elected Steven L. Martin, and Series D Preferred Stock holders elected Steven J. Baileys and Gene E. Burleson, all to serve until the 2026 annual meeting or earlier departure.

How did Regional Health Properties (RHEP) shareholders vote on Say-on-Pay?

Common stock shareholders approved, by non-binding vote, the compensation of the named executive officers, with more votes cast in favor than against or abstaining, along with broker non-votes reported.

What frequency of Say-on-Pay votes did Regional Health Properties (RHEP) shareholders prefer?

Common stock shareholders indicated a preference to hold advisory Say-on-Pay votes every three years, which received the highest number of votes compared with every year, every two years, or abstentions.

Who is the independent auditor for Regional Health Properties (RHEP) for 2025?

Common stock shareholders ratified the appointment of Cherry Bekaert, LLP as the company’s independent registered public accounting firm for the year ended December 31, 2025.

Where and when did Regional Health Properties (RHEP) hold its 2025 Annual Meeting of Shareholders?

The 2025 Annual Meeting of Shareholders was held on January 5, 2026 at 1050 Crown Pointe Parkway, Atlanta, Georgia 30338, at 1:00 p.m.

Regional Health

OTC:RHEP

RHEP Rankings

RHEP Latest News

RHEP Latest SEC Filings

RHEP Stock Data

6.91M
3.15M
18.47%
8.08%
Medical Care Facilities
Healthcare
Link
United States
Atlanta